Other
Research and development expense
Gilead Sciences Research and development expense decreased by 13.4% to $1.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $1.38B to $1.37B. Over 4 years (FY 2021 to FY 2025), Research and development expense shows an upward trend with a 5.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher spending typically signals a commitment to long-term innovation and future product pipelines, while significant cuts may signal a shift toward short-term profitability.
Detailed definition
This metric captures the investment in creating new products, improving existing technologies, and advancing internal ca...
Peer comparison
Standard metric for technology and hardware firms; highly comparable to R&D spending at peers.
Metric ID:
other_research_and_development_expense_excluding_acquire_88a3cdHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.09B | $1.10B | $1.36B | $1.18B | $1.10B | $1.15B | $1.55B | $1.45B | $1.41B | $1.46B | $1.41B | $1.52B | $1.35B | $1.40B | $1.64B | $1.38B | $1.49B | $1.35B | $1.58B | $1.37B |
| QoQ Change | — | +0.8% | +23.3% | -13.3% | -6.5% | +4.3% | +34.7% | -6.5% | -2.8% | +3.6% | -3.4% | +8.0% | -11.1% | +3.3% | +17.6% | -16.0% | +8.1% | -9.7% | +17.7% | -13.4% |
| YoY Change | — | — | — | — | +0.9% | +4.4% | +14.0% | +22.8% | +27.7% | +26.8% | -9.0% | +5.0% | -4.0% | -4.3% | +16.5% | -9.3% | +10.4% | -3.5% | -3.5% | -0.5% |
Range$1.09B – $1.64B
CAGR+4.9%
Avg YoY Growth+5.9%
Median YoY Growth+2.6%
Research and development expense at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's research and development expense?
- Gilead Sciences (GILD) reported research and development expense of $1.37B in Q1 2026.
- How has Gilead Sciences's research and development expense changed year-over-year?
- Gilead Sciences's research and development expense decreased by 0.5% year-over-year, from $1.38B to $1.37B.
- What is the long-term trend for Gilead Sciences's research and development expense?
- Over 4 years (2021 to 2025), Gilead Sciences's research and development expense has grown at a 5.9% compound annual growth rate (CAGR), from $4.61B to $5.80B.
- What does research and development expense mean?
- Spending on innovation and product development.